MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)
Open Access
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 526 (1), 156-160
- https://doi.org/10.1016/0006-8993(90)90264-c
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging miceExperimental Neurology, 1990
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐lifeJournal of Cellular Physiology, 1989
- Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated miceLife Sciences, 1989
- GM1 ganglioside protects against the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐ induced degeneration of nigrostriatal dopamine neurons in the black mouseActa Physiologica Scandinavica, 1988
- Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerveNeuroscience Letters, 1987
- VII. The biotransformation of MPTP and disposition of MPP+: Tge effects of agingLife Sciences, 1987
- Primary structure of bovine brain acidic fibroblast growth factor (FGF)Biochemical and Biophysical Research Communications, 1985
- IX. Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamineLife Sciences, 1985
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981